- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
MediciNova Inc (MNOV)
Track today's live MediciNova (MNOV) share price, performance and key data on this page with our current NASDAQ:MNOV stock exchange information. Analyse interactive charts and historical data, check technical buy and sell signals in real time, and follow the MediciNova share price on the NASDAQ exchange. Use the dropdown to switch exchange for the MNOV share price, head to our technical summary section, which provides analysis on MediciNova share price buy/sell indicators using real-time data (or discuss the MediciNova (MNOV) stock price today with other investors in the MediciNova NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ:MNOV share price (ISIN: US58468P2065) to enhance your trading decisions with our free investment tools and resources.
What Is the MediciNova Inc Share Price Today?
The MediciNova share price today is 3.320.
What Is the Stock Symbol for MediciNova Inc
The stock symbol (or 'ticker') for MediciNova Inc is "MNOV."
What Stock Exchange Does MediciNova Inc Trade On?
MediciNova Inc is listed and trades on the NASDAQ stock exchange.
Is MediciNova Inc a Good Stock to Buy?
Determining whether MediciNova (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Use the dropdown to select a relevant stock exchange for the current NASDAQ:MNOV share price (ISIN: US58468P2065) to enhance your trading decisions with our free investment tools and resources.
What Is the MediciNova Inc Share Price Today?
The MediciNova share price today is 3.320.
What Is the Stock Symbol for MediciNova Inc
The stock symbol (or 'ticker') for MediciNova Inc is "MNOV."
What Stock Exchange Does MediciNova Inc Trade On?
MediciNova Inc is listed and trades on the NASDAQ stock exchange.
Is MediciNova Inc a Good Stock to Buy?
Determining whether MediciNova (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.720
3.615
52 wk Range
1.168
3.900
Unusual trading volume
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.7203.615
52 wk Range
1.1683.900
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
MNOV Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
8.250
Upside
+148.49%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts anticipate sales growth in the current year
MediciNova receives Investment Bank Analyst Rating Update- Investing.com
Pro
- MediciNova receives Investment Bank Analyst Rating Update
- Investing.com
Pro 
- Form 8K MediciNova Inc For: 19 August
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Analyst Ratings
4 Buy
0 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 8.250
(+148.49% Upside)
Earnings
Latest Release
13/08/2026
EPS / Forecast
-0.05 / -0.08
Revenue / Forecast
460K / 65K
Compare MNOV to Peers and Sector
Metrics to compare | MNOV | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipMNOVPeersSector | |
|---|---|---|---|---|
P/E Ratio | −15.2x | −1.8x | −0.4x | |
PEG Ratio | −1.79 | −0.26 | 0.00 | |
Price/Book | 4.4x | 3.6x | 2.6x | |
Price / LTM Sales | 177.5x | 4.0x | 3.0x | |
Upside (Analyst Target) | 130.4% | 86.6% | 54.5% | |
Fair Value Upside | Unlock | 21.1% | 7.0% | Unlock |
MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. It develops MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent in Phase 2 clinical trial for treating neurological and other disorders, such as progressive multiple sclerosis, amyotrophic lateral sclerosis, chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, and glioblastoma, as well as prevention of acute respiratory distress syndrome. The company is also developing MN-001 (tipelukast), an orally bioavailable small molecule compound in Phase 2 clinical trial to treat fibrotic and other metabolic disorders, including nonalcoholic fatty liver disease and hypertriglycedemia. MediciNova, Inc. was incorporated in 2000 and is headquartered in La Jolla, California.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the MediciNova (NASDAQ: MNOV) Share Price Today?
The MediciNova stock price today is 3.320 USD.
What Stock Exchange Does MediciNova (MNOV) Trade On?
MediciNova is listed and trades on the Nasdaq Stock Exchange.
What Is the Ticker (Stock Symbol) for MediciNova?
The stock symbol (also called a 'ticker') for MediciNova is "MNOV."
What Is the Current MediciNova Market Capitalisation?
As of today, MediciNova (NASDAQ: MNOV) market cap is 169.810M USD.
What Is MediciNova's (MNOV) Earnings Per Share (TTM)?
The MediciNova EPS is currently -0.219 (Trailing Twelve Months).
When Is the Next MediciNova Earnings Date?
MediciNova's next earnings report will be released on 12/11/2026.
Is MNOV a Buy or Sell From a Technical Analyst Perspective?
Based on today's MediciNova moving averages and other technical indicators, the daily buy/sell signal for MNOV stock is Strong Buy.
How Many Times Has MediciNova Stock Split?
MediciNova has split 0 times. (See the MNOV stock split history page for full effective split date and price information.)
How Many Employees Does MediciNova Have?
MediciNova has 6 employees, based on their latest Companies House report.
What is the current trading status of MediciNova (NASDAQ: MNOV)?
As of 19/09/2026, MediciNova (MNOV) is trading at a share price of 3.320 USD, with a previous close of 3.320 USD. The stock has fluctuated within a day range of 2.720 USD to 3.615 USD, while its 52-week range spans from 1.168 USD to 3.900 USD.
What Is MediciNova (MNOV) Price Target According to Analysts?
The average 12-month price target for MediciNova is 8.250 USD, with a high estimate of 11 USD and a low estimate of 6 USD. 4 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +148.49% Upside potential.
What Is the MNOV Premarket Price?
MNOV's last pre-market stock price is 3.190 USD. The pre-market share volume is 149,760.000, and the stock has decreased by -0.260, or -7.540%.
What Is the MNOV After Hours Price?
MNOV's last after hours stock price is 3.344 USD, the stock has decreased by 0.024, or 0.720%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.